Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
|
+$629M |
| 2 |
AGN
Allergan plc
AGN
|
+$463M |
| 3 |
State Street SPDR S&P Aerospace & Defense ETF
XAR
|
+$350M |
| 4 |
iShares Biotechnology ETF
IBB
|
+$315M |
| 5 |
BPL
Buckeye Partners, L.P.
BPL
|
+$265M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$978M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$675M |
| 3 |
Apple
AAPL
|
+$429M |
| 4 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$387M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$344M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.7% |
| 2 | Healthcare | 5.71% |
| 3 | Financials | 4.62% |
| 4 | Consumer Discretionary | 4.5% |
| 5 | Communication Services | 3.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PRNB
4601
DELISTED
Principia Biopharma Inc. Common Stock
PRNB
| $288K | ﹤0.01% |
10,246
-34
| -0.3% | -$1.25K |
|
4602
AMC Entertainment Holdings
AMC
$2.39B
| $287K | ﹤0.01% |
2,689
-779
| -22% | -$84.8K |
|
4603
CALL
Popular Inc
BPOP
$11.2B
| $287K | ﹤0.01% |
5,300
-13,800
| -72% | -$748K |
|
|
EVRI
4604
DELISTED
Everi Holdings
EVRI
| $287K | ﹤0.01% |
33,874
-81,180
| -71% | -$831K |
|
4605
Midland States Bancorp
MSBI
$717M
| $287K | ﹤0.01% |
11,009
-3,292
| -23% | -$86.3K |
|
4606
QCR Holdings
QCRH
$1.72B
| $287K | ﹤0.01% |
7,565
-2,254
| -23% | -$81.6K |
|
|
WIRE
4607
CALL
DELISTED
Encore Wire Corp
WIRE
| $287K | ﹤0.01% |
+5,100
| New | +$283K |
|
|
CNR
4608
DELISTED
Cornerstone Building Brands, Inc.
CNR
| $287K | ﹤0.01% |
47,286
-23,930
| -34% | -$131K |
|
4609
First Financial Corp
THFF
$985M
| $286K | ﹤0.01% |
6,576
-1,366
| -17% | -$56.8K |
|
|
STFC
4610
DELISTED
State Auto Financial Corp
STFC
| $286K | ﹤0.01% |
8,830
-2,561
| -22% | -$85.7K |
|
4611
CALL
ProShares UltraShort QQQ
QID
$247M
| $285K | ﹤0.01% |
475
-30
| -6% | -$18.2K |
|
4612
Compañía de Minas Buenaventura
BVN
$8.19B
| $284K | ﹤0.01% |
18,702
-64,794
| -78% | -$1M |
|
4613
CALL
Robert Half
RHI
$4.19B
| $284K | ﹤0.01% |
5,100
-5,100
| -50% | -$288K |
|
|
PETQ
4614
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
| $284K | ﹤0.01% |
10,410
-3,103
| -23% | -$98.2K |
|
|
DPLO
4615
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
| $284K | ﹤0.01% |
58,018
-8,682
| -13% | -$48.6K |
|
4616
CALL
Foster
FSTR
$438M
| $282K | ﹤0.01% |
13,000
+12,900
| +12,900% | +$299K |
|
4617
CALL
Halozyme
HALO
$9.87B
| $282K | ﹤0.01% |
18,200
-2,100
| -10% | -$34.6K |
|
|
TARO
4618
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
| $282K | ﹤0.01% |
3,732
+66
| +2% | +$5.36K |
|
4619
PUT
Canadian Imperial Bank of Commerce
CM
$108B
| $281K | ﹤0.01% |
6,800
+3,200
| +89% | +$126K |
|
4620
CALL
Trinity Industries
TRN
$2.55B
| $281K | ﹤0.01% |
14,265
+12,100
| +559% | +$229K |
|
|
CIT
4621
CALL
DELISTED
CIT Group Inc.
CIT
| $281K | ﹤0.01% |
6,200
-5,700
| -48% | -$266K |
|
4622
Collegium Pharmaceutical
COLL
$1.16B
| $280K | ﹤0.01% |
24,408
+2,108
| +9% | +$24.1K |
|
|
FFIC
4623
DELISTED
Flushing Financial
FFIC
| $280K | ﹤0.01% |
13,853
-4,135
| -23% | -$84.5K |
|
4624
PUT
Synaptics
SYNA
$4.16B
| $280K | ﹤0.01% |
7,000
-5,000
| -42% | -$169K |
|
4625
Accuray
ARAY
$37.2M
| $279K | ﹤0.01% |
100,500
-595,117
| -86% | -$1.97M |
|
Similar funds
Barclays's Q3 2019 Portfolio in Review
As of Q3 2019, Barclays held 7,551 positions worth $160B, down 2.1% from $163B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Barclays's Q3 2019 filing shows 501 new, 2,626 increased, 3,452 reduced and 568 closed positions. Its largest new stake was State Street SPDR S&P Aerospace & Defense ETF: 3,300,000 shares worth $353M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $978M.
By sector, the portfolio is most concentrated in Technology at 7.7% of assets, down from 8.5% a quarter earlier, followed by Healthcare and Financials.
- Barclays's largest Q3 2019 buy was State Street SPDR S&P Aerospace & Defense ETF: 3,300,000 shares worth $353M.
- Barclays added most to iPath Series B S&P 500 VIX Short-Term Futures ETN in Q3 2019, an estimated $629M increase.
- Barclays's biggest Q3 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $978M.
- Barclays fully exited Anadarko Petroleum in Q3 2019, selling an estimated $309M.
- Barclays's ten largest holdings make up 28% of its $160B portfolio in Q3 2019.
- Barclays opened 501 new positions and closed 568 in Q3 2019.
- Barclays's portfolio value fell 2.1% quarter-over-quarter to $160B.
Based on Barclays's 13F filing for Q3 2019, filed 14 Nov 2019.